Postpartum misoprostol for preventing maternal mortality and morbidity (Q24201196)

3

object named as

Natalia Novikova

0 references

Theresa A. Lawrie

object named as

Theresa A Lawrie

4

0 references

A Metin Gülmezoglu

2

object named as

A Metin Gülmezoglu

0 references

author name string

Natalia Novikova

Cochrane Database of Systematic Reviews

3

0 references

language of work or name

English

0 references

publication date

15 July 2013

0 references

published in

0 references

issue

7

0 references

page(s)

CD008982

0 references

cites work

A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol versus oxytocin for the reduction of postpartum blood loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Sublingual misoprostol versus methylergometrine for active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Oral misoprostol versus injectable methylergometrine in management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Oral misoprostol in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Conducting international collaborative research in developing nations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Variation in the postpartum hemorrhage rate in a clinical trial of oral misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Sublingual misoprostol to reduce blood loss at cesarean delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A double‐blind, randomized, placebo‐controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Buccal misoprostol to decrease blood loss after vaginal delivery: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

WHO multicentre randomised trial of misoprostol in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol versus oxytocin in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

The use of rectal misoprostol as active pharmacological management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Optimization of third-stage management after second-trimester medical pregnancy termination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Oral misoprostol versus oxytocin in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Controlling postpartum hemorrhage after home births in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Prevention of postpartum hemorrhage at home birth in Afghanistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

External aortic compression device: the first aid for postpartum hemorrhage control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

No reduction of manual removal after misoprostol for retained placenta: a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol versus methylergometrine: pharmacokinetics in human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

The effect of post-cesarean rectal misoprostol on intestinal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Effects of misoprostol on human circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Severe hyperthermia following oral misoprostol in the immediate postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Prevention of postpartum hemorrhage with misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Treatment of postpartum hemorrhage with misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Treatment for primary postpartum haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: cost-effectiveness, mortality, and morbidity reduction analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Prostaglandins for preventing postpartum haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

The efficacy of oral misoprostol in preventing postpartum hemorrhage in a community setting: A randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

Rectal misoprostol vs. 15-methyl prostaglandin F2alpha for the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Evaluation of two uterotonic medications for the management of the third stage of labor

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Impact of preoperative rectal misoprostol on blood loss during and after elective cesarean delivery

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

A double-blind randomized controlled trial to compare sublingual misoprostol with methylergometrine for prevention of postpartum hemorrhage

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Rectal misoprostol versus oxytocin in the prevention of postpartum hemorrhage - A pilot study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Preliminary progress report: Randomized double-blind trial of Zhi Byed 11 , a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Rectal misoprostol versus oxytocin in the management of the third stage of labour.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008982.PUB2

7 January 2021

10.1002/14651858.CD008982.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23857523

1 reference

Consolidated OpenCitations Corpus – April 2017